Valencia-based Avita Medical Inc. has received FDA approval for a version of its second-generation Recell skin cell ...
Inc. (NASDAQ:RCEL), recently acquired 486 shares of the company's common stock. The transaction, dated December 9, 2024, was executed at a price of $13.15 per share, amounting to a total purchase ...
ONTARIO — Chief Tommy Hill assured there was no active shooter incident at Avita Hospital, despite social media rumors.
After hours: January 28 at 4:25:30 PM EST Loading Chart for RCEL ...
Commercialisation of the Company's regenerative product.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback